Since the dawn of the opioid epidemic, there has been no more frightening and foreboding villain than Fentanyl. Fentanyl is a type of synthetic opioid that has been used for years for medical procedures such as post-surgery, to block pain or before surgery in order to ease people gently into an unconscious state. The drug was developed in the 1960’s as an anesthetic and pain blocker. At the time it was well regulated and was more or less available via prescription only, however as it became available via a subdermal patch, in the 1990’s, a type of dosage and administration that can be easily taken care of at home or out and about. Since the patch, fentanyl use has exploded in the United States. The drug took off as easy as if it were vicodin or codeine, only to a much much more deadly affect. Fentanyl causes almost half of all of the drug overdose deaths in the United States by itself.  It is anywhere from fifty to one hundred times more powerful than morphine and heroin are.

 

With all of that in mind, it is understandable that there are some physicians and specialists out there who are very nervous about the fact that the US Food and Drug Association are about to approve usage of a new opioid, Dsuvia, that is ten times more deadly than fentanyl is. Dsuvia was developed by AcelRx Pharmaceuticals.

“Even among committee members, there is disagreement about the necessity of releasing another potent opioid to the public. Dr. Raeford Brown, the chair of the committee and a professor of anesthesiology and pediatrics at the University of Kentucky, expressed concern about Dsuvia, which he noted comes in a form that can be easily diverted—meaning someone without a prescription might still be able to access the drug. “This drug offers no advance, in my mind, over previously available opioid formulations, but provides great risk of harm to patients and the general public health,” Brown told Marketwatch in an interview.”

(http://fortune.com/2018/10/22/fda-new-opioid-dsuvia-sufentanil-stronger-than-fentanyl/?fbclid=IwAR1UJuOE7-TjqOz1YrF70a2So6dGgGvIUvjFPJa9CndRdfdVm86C55T7HXA)

 

Opioid Addiction Treatment in New Jersey Detox

Discovery InstituteOpioid addiction has been such a problem in New Jersey that the local government is suing Purdue Pharma, the drug company responsible for OxyContin. The New Jersey representatives claim that the company created false marketing around the drug causing a higher rate of addiction to a drug that can lead to deadly consequences.

At Discovery Institute New Jersey drug detox and drug rehab, NJ residents and out of state patients as well can receive excellent care in a comfortable environment. Opioid addiction is no joke and often leads to a life or death situation. Call today to learn more about our life saving programs.

Reviewed for Medical & Clinical Accuracy by Dr. Jeffrey Berman, MD

Dr. Jeffrey Berman, MDDr. Jeffrey Berman is a psychiatrist in Teaneck, New Jersey and is affiliated with Robert Wood Johnson University Hospital. He received his medical degree from State University of New York Upstate Medical University and has been in practice for more than 20 years. He also speaks multiple languages, including French and Hebrew.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>